Acura Pharmaceuticals, Inc. (NASDAQ:ACUR)
|
5.37 -0.13 (-2.36%) 11:44EST Delayed |
|
|
|
- Compare ACUR with:
- View: Line | Candlestick
Company Profile
Acura Pharmaceuticals, Inc.
616 N.North Court
Palatine, IL 60067
United States - Map
Phone: (847) 705-7709
Fax: (847) 705-5399
Website: www.acurapharm.com
State of incorporation: New York
CEO: Andrew D. Reddick
Employees: 15
Sector: Other
Industry Group: Other
Industry: Other
Mfr/mkt generic drug prods
A specialty pharmaceutical company, which is engaged in the research, development and manufacture of product candidates providing abuse deterrent features and benefits.
Recent news for ACUR
-
Acura, King cite positive study on pain drug
AP - Mar 08 at 6:07PM (EST)
-
ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events
EDGAR Online - Mar 08 at 5:19PM (EST)
-
Marketwire - Mar 08 at 4:05PM (EST)
-
Briefing.com - Mar 08 at 4:05PM (EST)
-
ACURA PHARMACEUTICALS, INC Financials
EDGAR Online Financials - Mar 06 at 1:04PM (EST)
-
EDGAR Online - Mar 02 at 4:06PM (EST)
-
Acura Pharmaceuticals Reports Year-End and Fourth Quarter 2009 Financial Results
GlobeNewswire - Mar 02 at 4:05PM (EST)
-
ACURA PHARMACEUTICALS, INC Files SEC form 10-K, Annual Report
EDGAR Online - Mar 02 at 4:04PM (EST)
-
Wall Street Transcript - Jan 25 at 9:55AM (EST)
-
ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online - Dec 10 2009 at 4:13PM (EST)